Prospect Venture Partners is a leading life sciences venture capital firm dedicated to building outstanding biomedical companies. With more than $1B of capital raised, Prospect Ventures supports innovative companies from seed to growth stage. We seek to partner with exceptional teams committed to excellence.
Prospect Ventures management team:
Managing Director, Russell Hirsch
Managing Director, David Schnell
CFO, Lisa Potocsnak
https://www.prospectventurepartners.com/partners/
Location: United States, California, Palo Alto
Employees: 1-10
Founded date: 1997
Investment Type: Venture Capital
Portfolio 18
| Date | Name | Website | Total Raised | Location |
| - | investor.j... | - | - | |
| - | Nanosys | nanosysinc... | $60M | United Sta... |
| - | Senomyx, I... | senomyx.co... | - | - |
| - | PharmaTime... | pharmatime... | - | United Kin... |
| - | Novavax | novavax.co... | - | United Sta... |
| - | Infinity P... | infi.com | - | United Sta... |
| - | Fierce Bio... | fiercebiot... | - | United Sta... |
| - | Ninepoint ... | ninepointm... | $67M | United Sta... |
| - | SentreHEAR... | sentrehear... | $61M | - |
| - | The Wall S... | wsj.com | - | United Sta... |
Show more
News 68
Show more
Mentions in press and media 17
| Date | Title | Description | Source |
| 08.11.2011 | DFINE Closes $25M Equity Financing | DFINE, Inc., a San Jose, CA-based developer of minimally invasive radiofrequency (RF) targeted thera... | finsmes.co... |
| 18.10.2011 | TOPICA Pharmaceuticals Raises $27M in Series B Funding | TOPICA Pharmaceuticals, Inc., a Palo Alto, CA-based clinical research stage pharmaceutical company, ... | finsmes.co... |
| 24.08.2009 | Complete Genomics seals $45M for cheaper gene sequencing | Complete Genomics, provider of supposedly cheaper and faster DNA sequencing services, has raised $45... | venturebea... |
| 24.08.2009 | Complete Genomics seals $45M for cheaper gene sequencing | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an... | venturebea... |
| 04.02.2009 | Allux Medical shuts down, turns to Sherwood | Silicon Valley shutdown/turnaround consultancy Sherwood Partners has been called in by ailing Allux ... | venturebea... |
| 28.01.2009 | Cardiovascular drug developer Cogentus files for Chapter 7 | Menlo Park, Calif.-based Cogentus Pharmaceuticals has filed for Chapter 7 bankruptcy, despite $83 mi... | venturebea... |
| 08.01.2009 | Satori brings in $22M to stop Alzheimer’s in its tracks | Satori Pharmaceuticals, a company that says it’s developing drugs with the potential to actually sto... | venturebea... |
| 05.01.2009 | DFine secures $35M to treat spinal fractures | Medical device maker DFine brought in $35 million in fourth round funding to develop and market its ... | venturebea... |
| 29.10.2008 | DFine stacks up $30M to mend spinal fractures | Healthcare developer DFine has brought in $30 million in fourth-round funding to commercialize a sys... | venturebea... |
| 23.10.2008 | Nora Pharma reels in $25M for women’s health | Nora Pharmaceuticals, developer of women’s reproductive health drugs and devices, brought in $25 mil... | venturebea... |
Show more